Thrive Capital Management, LLC Abbott Laboratories Transaction History

Thrive Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $177,313 - $217,046	1,966 New	1,966 $216,000
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $201,131 - $245,266	-1,764 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $329,260 - $403,161	-2,850 Reduced 61.77%	1,764 $248,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $18,198 - $20,133	156 Added 3.5%	4,614 $545,000
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $191,162 - $225,025	1,807 Added 68.16%	4,458 $517,000
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $288,534 - $339,937	2,651 New	2,651 $318,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Thrive Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Thrive Capital Management, LLC with notifications on news.